BioHealth News Archive

Shepherd Entrepreneurship and Research Corporation achieves nonprofit status | News, Sports, Jobs – Journal News

Shepherd Entrepreneurship and Research Corporation achieves nonprofit status | News, Sports, Jobs – Journal News

Shepherd University has created a new nonprofit organization with a mission of helping facilitate research, innovation, and entrepreneurship. On January 24, the Internal Revenue…

Read More
New report highlights New York City’s health tech and life science investment landscape – MedCity News

New report highlights New York City’s health tech and life science investment landscape – MedCity News

By StartUp Health’s reckoning, New York City was the second most active city for health tech dealflow in 2017 with $1 billion invested across 63…

Read More
Teva Pharmaceuticals chairman, former Medtronic CEO invest in NexImmune – Washington Business Journal

Teva Pharmaceuticals chairman, former Medtronic CEO invest in NexImmune – Washington Business Journal

The company overcame early funding challenges with the help of influential backing. {iframe}https://www.bizjournals.com/washington/news/2018/02/09/gaithersburg-biotech-raises-21-7m-from-a-whos-who.html{/iframe}

Read More
MD Momentum Fund Backs Stroke Recovery Firm – University of Maryland, Baltimore

MD Momentum Fund Backs Stroke Recovery Firm – University of Maryland, Baltimore

The University System of Maryland (USM) has selected NextStep Robotics, a startup company that has developed a personalized robotic therapy to help relieve discomforts…

Read More
NextStep Robotics moves towards $750,000 · Articles · Global University Venturing

NextStep Robotics moves towards $750,000 · Articles · Global University Venturing

NextStep Robotics, a US-based medical device manufacturer based on research at several Maryland institutions, has raised $750,000 in funding from investors including the Maryland…

Read More
GlycoMimetics Enters into Agreement with HOVON to Initiate Study Startup Activities for Planned Clinical Trial of GMI-1271 and Decitabine in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Unfit for Chemotherapy | GlycoMimetics, Inc.

GlycoMimetics Enters into Agreement with HOVON to Initiate Study Startup Activities for Planned Clinical Trial of GMI-1271 and Decitabine in Patients with Newly Diagnosed Acute Myeloid Leukemia (AML) Who Are Unfit for Chemotherapy | GlycoMimetics, Inc.

GlycoMimetics, Inc. (NASDAQ: GLYC) announced today that it has entered into an agreement with the Haemato Oncology Foundation for Adults in the Netherlands (HOVON)…

Read More
Rexahn Pharmaceuticals Announces Collaboration with Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin®) for the treatment of Hepatocellular Carcinoma (NYSE:RNN)

Rexahn Pharmaceuticals Announces Collaboration with Zhejiang Haichang Biotechnology Co., Ltd. for the Development of RX-0201 (Archexin®) for the treatment of Hepatocellular Carcinoma (NYSE:RNN)

Rexahn Pharmaceuticals, Inc. (NYSE American:RNN), a clinical stage biopharmaceutical company developing innovative, targeted therapeutics for the treatment of cancer, today announced that it has…

Read More
Camden Partners Nexus leads Series D funding for eNeura – Technical.ly Baltimore

Camden Partners Nexus leads Series D funding for eNeura – Technical.ly Baltimore

eNeura, a Baltimore-based company that makes a device to treat migraines, closed a Series D investment round. {iframe}https://technical.ly/baltimore/2018/02/07/eneura-series-d/?utm_campaign=Baltimore%20Editorial%20Email&utm_source=hs_email&utm_medium=email&utm_content=60524211&_hsenc=p2ANqtz-9YbUTHzl7CgsO3ktA4RcHxPWs4NtN7Pm_88OF81IG_r5RSj6725zBWUkP7MgUBAG_Teo8Zr41ouV_zCni6rWFudx4p4w&_hsmi=60524211{/iframe}

Read More
BioBuzz with BioIT Solutions in Rockville on Feb 13th!

BioBuzz with BioIT Solutions in Rockville on Feb 13th!

When: Tuesday, February 13, 2018 from 5:00 PM to 7:00 PM EST Where: Bar Louie 150 Gibbs St Rockville, MD 20850 Join BioBuzz and…

Read More
Orgenesis and Adva Biotechnology to Develop and Distribute Advanced Automated Culturing System for Cell Therapy Manufacturing | StockGuru SmallCap Alerts on Penny Stocks

Orgenesis and Adva Biotechnology to Develop and Distribute Advanced Automated Culturing System for Cell Therapy Manufacturing | StockGuru SmallCap Alerts on Penny Stocks

Orgenesis Inc., (OTCQB:ORGS), a service and research company in the field of the regenerative medicine industry with a focus on cell therapy development and…

Read More
Racefor7 Brings India, United States Closer by Honoring Patients with Rare Diseases – Washington Business Journal

Racefor7 Brings India, United States Closer by Honoring Patients with Rare Diseases – Washington Business Journal

On Sunday, Feb. 25, 2018, the Organization for Rare Diseases India (ORDI), is holding simultaneous walks or races in Bengaluru, Mumbai, and Washington, D.C.…

Read More
The 19 Biggest Venture Deals of 2017 (and early 2018) – BuiltWorlds

The 19 Biggest Venture Deals of 2017 (and early 2018) – BuiltWorlds

Dovetailing off our Top 27 Venture Players report, we’ve put together the 19 largest AEC and real estate venture rounds of the past year.…

Read More
The Convergence of Medicine and Technology – PharmaVOICE

The Convergence of Medicine and Technology – PharmaVOICE

Imagine instead of a pill, a doctor prescribes a game for a child with attention deficit disorder. Or imagine patients dealing with substance abuse…

Read More
USM Venture Capital Fund Supports $750,000 Investment in Stroke Recovery Technology – USM

USM Venture Capital Fund Supports $750,000 Investment in Stroke Recovery Technology – USM

The University System of Maryland (USM) has selected NextStep Robotics, a start-up company that has developed a personalized robotic therapy to help relieve discomforts…

Read More
Frederick’s Mid-Atlantic Angels Optimistic for Year Ahead

Frederick’s Mid-Atlantic Angels Optimistic for Year Ahead

Mid-Atlantic Angels, LLC (MAA) approaches its 2018 programming in an environment of economic optimism that leverages the economic upsurge of 2017. With the strengthening…

Read More